Caffeine intake during gum disease treatment
Part of Mouth & dental clinical trials.
This study tests whether drinking caffeine affects the success of standard gum disease treatment. If you have gum disease, you may be asked to either consume caffeine or avoid it during your treatment to see if it helps your gums heal better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must have gum disease (periodontitis) diagnosed by a dentist, and this is your first time getting treatment for it.
- You must be willing to follow the study's caffeine diet plan and attend all follow-up visits.
- You cannot be pregnant, planning pregnancy, or breastfeeding during the study.
- You must not have had gum treatment in the last 6 months, and you must not smoke or use tobacco.
- You must not have taken certain medications (like antibiotics or anti-inflammatory drugs) in the last 3 months, and you must not have major health conditions like diabetes, high blood pressure, or high cholesterol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the timing between gum disease detection and treatment affects the outcome. It aims to understand if waiting longer before treatment changes results, so you'll receive standard periodontal care while researchers track your progress.
This trial tests whether an anti-inflammatory diet can improve the results of standard gum disease treatment. It is for people diagnosed with periodontitis who are otherwise healthy and do not smoke.
This study looks at how treating advanced gum disease (periodontitis) affects your ability to chew and the force of your bite. If you have severe gum disease and haven't had gum treatment in the past year, you may be able to join and help us learn if treatment improves chewing function.
This study looks at how smoking and nicotine affect the success of gum disease treatment. It compares results between smokers and non-smokers who have gum disease.
This study tests whether treating moderate to severe gum disease can lower your risk of heart disease and stroke. You would receive non-surgical gum treatment and be followed over time to see how it affects your heart health.
This trial is testing whether a GLP-1 receptor agonist (a medicine used for diabetes) helps treat gum disease (periodontitis) in people with type 2 diabetes. It might show that this medication improves gum health as a side benefit.
Hear when a new Periodontitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.